MAPK3 and colorectal carcinoma: A previous study revealed that phosphorylated AMP-activated protein kinase (AMPK) expression in CRC was associated with superior prognosis among p-MAPK3 positive cases, indicating a possible interaction between the AMPK and MAPK pathways influencing tumor behavior [46].